LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”),…
PHILADELPHIA, PA, Aug 16, 2023 – (ACN Newswire) – In addition to helping alleviate a…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
The partnership will provide community OneOncology Research Network sites with new tools to accelerate clinical…
Machine learning models will allow CMP, NYSEG, RG&E and UI to forecast grid performance ahead…
Nashville Fintech Becomes Popular Music Venue’s Preferred Payments Partner NASHVILLE, Tenn.–(BUSINESS WIRE)–#BluebirdCafe—Celero Commerce (“Celero”), a…
At the recent TCT 3Sixty event in Birmingham, 3DPRINTUK ran a competition offering vouchers to…
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or…
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or…
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with…
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with…
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023…
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023…
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Initial data show clinical responses from four of four indolent lymphoma patients, including complete response…
Initial data show clinical responses from four of four indolent lymphoma patients, including complete response…
BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
Transformative Period Led by Acquisition of TeraImmune Company to Prioritize Development of New TI-168 Treg…